143 related articles for article (PubMed ID: 33794728)
1. Acute gastrointestinal bleeding among patients on antiplatelet and anticoagulant therapy after percutaneous coronary intervention.
Sveinsdottir A; Gudmundsdottir IJ; Hreinsson JP; Andersen K; Björnsson ES
Scand J Gastroenterol; 2021 Jun; 56(6):733-739. PubMed ID: 33794728
[TBL] [Abstract][Full Text] [Related]
2. Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
Patel NJ; Pau D; Nalluri N; Bhatt P; Thakkar B; Kanotra R; Agnihotri K; Ainani N; Patel N; Patel N; Shah S; Kadavath S; Arora S; Sheikh A; Badheka AO; Lafferty J; Alfonso C; Cohen M
Am J Cardiol; 2016 Oct; 118(8):1150-1157. PubMed ID: 27642112
[TBL] [Abstract][Full Text] [Related]
3. [The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
Zhang ZF; Sha WH; Tan GY; Wang QY
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):445-50. PubMed ID: 27256606
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
Koskinas KC; Räber L; Zanchin T; Wenaweser P; Stortecky S; Moschovitis A; Khattab AA; Pilgrim T; Blöchlinger S; Moro C; Jüni P; Meier B; Heg D; Windecker S
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25910501
[TBL] [Abstract][Full Text] [Related]
5. Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary intervention.
Zhu P; Tang X; Xu J; Song Y; Liu R; Zhang Y; Gao L; Gao Z; Chen J; Yang Y; Gao R; Xu B; Yuan J
Cardiovasc Ther; 2018 Oct; 36(5):e12440. PubMed ID: 29863803
[TBL] [Abstract][Full Text] [Related]
6. Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age.
Abraham NS; Noseworthy PA; Inselman J; Herrin J; Yao X; Sangaralingham LR; Cornish G; Ngufor C; Shah ND
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):337-346.e19. PubMed ID: 31108228
[TBL] [Abstract][Full Text] [Related]
7. Impact of bleeding event for new cancer diagnosis in patients with antiplatelet therapy after percutaneous coronary intervention.
Sakuma Y; Shimizu T; Kurosawa Y; Ohara H; Muto Y; Sato Y; Kiko T; Sato A; Misaka T; Yoshihisa A; Yamaki T; Nakazato K; Ishida T; Takeishi Y
J Cardiol; 2023 Dec; 82(6):460-466. PubMed ID: 37086970
[TBL] [Abstract][Full Text] [Related]
8. Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention.
Abraham NS; Yang EH; Noseworthy PA; Inselman J; Yao X; Herrin J; Sangaralingham LR; Ngufor C; Shah ND
Aliment Pharmacol Ther; 2020 Aug; 52(4):646-654. PubMed ID: 32657466
[TBL] [Abstract][Full Text] [Related]
9. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
[No Abstract] [Full Text] [Related]
10. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of ulcer bleeding risk factors in dual antiplatelet-treated patients after percutaneous coronary intervention.
Jensen BE; Hansen JM; Junker AB; Lassen JF; Jensen SE; Schaffalitzky de Muckadell OB
Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036886
[TBL] [Abstract][Full Text] [Related]
13. Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial.
Sherwood MW; Cyr DD; Jones WS; Becker RC; Berkowitz SD; Washam JB; Breithardt G; Fox KA; Halperin JL; Hankey GJ; Singer DE; Piccini JP; Nessel CC; Mahaffey KW; Patel MR
JACC Cardiovasc Interv; 2016 Aug; 9(16):1694-702. PubMed ID: 27539689
[TBL] [Abstract][Full Text] [Related]
14. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients.
Abraham NS; Hartman C; Richardson P; Castillo D; Street RL; Naik AD
Circulation; 2013 Oct; 128(17):1869-77. PubMed ID: 24025594
[TBL] [Abstract][Full Text] [Related]
15. In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry.
Yashima F; Inohara T; Nishida H; Shimoji K; Ueno K; Noma S; Yamaji K; Ishii H; Tanaka N; Kohsaka S; Amano T; Ikari Y
J Cardiovasc Pharmacol; 2021 Apr; 78(2):221-227. PubMed ID: 34554675
[TBL] [Abstract][Full Text] [Related]
16. Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy.
Fanaroff AC; Li S; Marquis-Gravel G; Giri J; Lopes RD; Piccini JP; Wang TY
Circ Cardiovasc Interv; 2021 Dec; 14(12):e011232. PubMed ID: 34932388
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting.
Lacoste JL; Hansen CL
Am J Health Syst Pharm; 2019 Sep; 76(18):1395-1402. PubMed ID: 31505555
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
Kopin D; Jones WS; Sherwood MW; Wojdyla DM; Wallentin L; Lewis BS; Verheugt FWA; Vinereanu D; Bahit MC; Halvorsen S; Huber K; Parkhomenko A; Granger CB; Lopes RD; Alexander JH
Am Heart J; 2018 Mar; 197():133-141. PubMed ID: 29447773
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
20. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
